Epic Corporation Share Price Other OTC
Equities
US29428L2051
Blockchain & Cryptocurrency
End-of-day quote
Other stock markets
|
||
- USD | - |
2022 | Sanofi profit gain beats market view on bestseller drug Dupixent | RE |
2022 | Sanofi to float drug ingredients manufacturing business on May 6 | RE |
Sales 2008 | 22.12K 1.73M | Sales 2009 | 5.22K 409K | Capitalization | 563K 44.13M |
---|---|---|---|---|---|
Net income 2008 | - 0 | Net income 2009 | - 0 | EV / Sales 2008 | 33.3 x |
Net Debt 2008 | 399K 31.31M | Net Debt 2009 | 673K 52.78M | EV / Sales 2009 | 237 x |
P/E ratio 2008 |
-0.98
x | P/E ratio 2009 |
-1.34
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 30/09/97 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald S. Tucker
CEO | Chief Executive Officer | 84 | 30/09/97 |
1st Jan change | Capi. | |
---|---|---|
+40.87% | 58.36B | |
+83.51% | 10.85B | |
+10.35% | 1.1B | |
+82.86% | 581M | |
-47.78% | 531M | |
+189.44% | 508M | |
-52.94% | 347M | |
-.--% | 118M | |
-71.21% | 108M |